The Assessment of Serum Apelin-12 Level in a Variety of Pulmonary Malignancies in Smokers

Document Type : Original Article


1 Pulmonology Ward, Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, Iran

2 Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran

3 Solid Tumor Research Center, Urmia University of Medical Sciences, Urmia, Iran

4 Eghbal Health Center, Urmia University of medical Sciences, Urmia, Iran


Background: Apelin has recently been considered as an adipokine secreted from visceral fat. Apelin and its
receptor exist in many tissues including lung and play significant roles in many physiological and
pathological activities. However, serum level of apelin-12 is unknown in smokers and in various types of lung
malignancies. Therefore, the amount of this hormone in non-patient smokers and the correlation of apelin
serum level with the types of lung cancer in smokers afflicted with lung cancer are evaluated in this study.
Methods: The amount of serum apelin-12 was measured in 63 patients (59 smokers and 4 non-smokers) with
the variety of lung cancer and 61 age- and sex-matched controls (30 smokers and 31 non-smokers) using
enzyme-linked immunosorbent assay (ELISA) kit.
Findings: The amount of serum apelin-12 in non-patient smokers (2142.20 ± 843.61 ng/l) was significantly
higher than healthy non-smokers (800.39 ± 336.01 ng/l, P < 0.05), and in the variety of lung malignancies,
the amount of serum apelin-12 was 2205.54 ± 187.31 ng/l in patients with squamous cell carcinoma (SCC)
which was a significant increase compared to 1088.00 ± 136.52 ng/l in adenocarcinoma, 797.25 ± 88.69 ng/l
in small cell carcinoma, and 1000.37 ± 62.87 ng/l in other malignancies of lung.
Conclusion: The meaningful increase in apelin-12 levels of non-patient smokers can be considered as a risk
factor for outbreaking of lung SCC in these people. Therefore, apelin-12 may be considered as a target in
controlling lung SCC.


Ntikoudi E, Kiagia M, Boura P, Syrigos KN.
Hormones of adipose tissue and their biologic role in
lung cancer. Cancer Treat Rev 2014; 40(1): 22-30.
2. Ouchi N, Ohashi K, Shibata R, Murohara T.
Adipocytokines and obesity-linked disorders.
Nagoya J Med Sci 2012; 74(1-2): 19-30.
3. Zhen EY, Higgs RE, Gutierrez JA. Pyroglutamyl
apelin-13 identified as the major apelin isoform in
human plasma. Anal Biochem 2013; 442(1): 1-9.
4. Kalin RE, Kretz MP, Meyer AM, Kispert A,
Heppner FL, Brandli AW. Paracrine and autocrine
mechanisms of apelin signaling govern embryonic
and tumor angiogenesis. Dev Biol 2007; 305(2):
5. Sorli SC, van den Berghe L, Masri B, Knibiehler B,
Audigier Y. Therapeutic potential of interfering with
apelin signalling. Drug Discov Today 2006; 11(23-
24): 1100-6.
6. O'Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC,
Kennedy JL, et al. A human gene that shows identity
with the gene encoding the angiotensin receptor is
located on chromosome 11. Gene 1993; 136(1 -2):
7. Kleinz MJ, Davenport AP. Emerging roles of apelin
in biology and medicine. Pharmacol Ther 2005;
107(2): 198-211.
8. Heinonen MV, Purhonen AK, Miettinen P,
Paakkonen M, Pirinen E, Alhava E, et al. Apelin,
orexin-A and leptin plasma levels in morbid obesity
and effect of gastric banding. Regul Pept 2005;
130(1-2): 7-13.
9. Bertrand C, Valet P, Castan-Laurell I. Apelin and
energy metabolism. Front Physiol 2015; 6: 115.
10. Kidoya H, Takakura N. Biology of the apelin-APJ
axis in vascular formation. J Biochem 2012; 152(2):
11. Yang Y, Lv SY, Ye W, Zhang L. Apelin/APJ system
and cancer. Clin Chim Acta 2016; 457: 112-6.
12. Diakowska D, Markocka-Maczka K, Szelachowski
P, Grabowski K. Serum levels of resistin,
adiponectin, and apelin in gastroesophageal cancer
patients. Dis Markers 2014; 2014: 619649.
13. Furrukh M. Tobacco Smoking and Lung Cancer:
Perception-changing facts. Sultan Qaboos Univ Med
J 2013; 13(3): 345-58.
14. Ferlay J, Shin HR, Bray F, Forman D, Mathers C,
Parkin DM. Estimates of worldwide burden of
cancer in 2008: GLOBOCAN 2008. Int J Cancer
2010; 127(12): 2893-917.
15. Hosseini M, Naghan PA, Karimi S, SeyedAlinaghi
S, Bahadori M, Khodadad K, et al. Environmental
risk factors for lung cancer in Iran: A case-control
study. Int J Epidemiol 2009; 38(4): 989-96.
16. Eggert JA, Palavanzadeh M, Blanton A. Screening
and early detection of lung cancer. Semin Oncol
Nurs 2017; 33(2): 129-40.
17. Vellappally S, Fiala Z, Smejkalova J, Jacob V,
Somanathan R. Smoking related systemic and oral
diseases. Acta Medica (Hradec Kralove) 2007;
50(3): 161-6.
18. Heo K, Kim YH, Sung HJ, Li HY, Yoo CW, Kim
JY, et al. Hypoxia-induced up-regulation of apelin is
associated with a poor prognosis in oral squamous
cell carcinoma patients. Oral Oncol 2012; 48(6):
19. Cox CM, D'Agostino SL, Miller MK, Heimark RL,
Krieg PA. Apelin, the ligand for the endothelial Gprotein-coupled receptor, APJ, is a potent angiogenic
Assessment of Apelin in Pulmonary Malignancies Gholamnejad et al.
98 Addict Health, Spring 2019; Vol 11, No 2, 04 April
factor required for normal vascular development of
the frog embryo. Dev Biol 2006; 296(1): 177-89.
20. Eyries M, Siegfried G, Ciumas M, Montagne K,
Agrapart M, Lebrin F, et al. Hypoxia-induced apelin
expression regulates endothelial cell proliferation
and regenerative angiogenesis. Circ Res 2008;
103(4): 432-40.
21. Machura E, Ziora K, Ziora D, Swietochowska E,
Krakowczyk H, Halkiewicz F, et al. Serum apelin-12
level is elevated in schoolchildren with atopic
asthma. Respir Med 2013; 107(2): 196-201.
22. Lv D, Li L, Lu Q, Li Y, Xie F, Li H, et al. PAK1-
cofilin phosphorylation mediates human lung
adenocarcinoma cells migration induced by apelin-13.
Clin Exp Pharmacol Physiol 2016; 43(5): 569-79.
23. Kawamata Y, Habata Y, Fukusumi S, Hosoya M,
Fujii R, Hinuma S, et al. Molecular properties of
apelin: tissue distribution and receptor binding.
Biochim Biophys Acta 2001; 1538(2-3): 162-71.
24. Berta J, Kenessey I, Dobos J, Tovari J, Klepetko W,
Jan AH, et al. Apelin expression in human non-small
cell lung cancer: role in angiogenesis and prognosis.
J Thorac Oncol 2010; 5(8): 1120-9.
25. Yang L, Su T, Lv D, Xie F, Liu W, Cao J, et al.
ERK1/2 mediates lung adenocarcinoma cell
proliferation and autophagy induced by apelin-13.
Acta Biochim Biophys Sin (Shanghai) 2014; 46(2):
26. Sorli SC, Le GS, Knibiehler B, Audigier Y. Apelin is
a potent activator of tumour neoangiogenesis.
Oncogene 2007; 26(55): 7692-9.
27. Han S, Wang G, Qi X, Lee HM, Englander EW,
Greeley GH, Jr. A possible role for hypoxia-induced
apelin expression in enteric cell proliferation. Am J
Physiol Regul Integr Comp Physiol 2008; 294(6):
28. Wang G, Anini Y, Wei W, Qi X, OCarroll AM,
Mochizuki T, et al. Apelin, a new enteric peptide:
localization in the gastrointestinal tract, ontogeny,
and stimulation of gastric cell proliferation and of
cholecystokinin secretion. Endocrinology 2004;
145(3): 1342-8.
29. Peng X, Li F, Wang P, Jia S, Sun L, Huo H. Apelin-
13 induces MCF-7 cell proliferation and invasion via
phosphorylation of ERK1/2. Int J Mol Med 2015;
36(3): 733-8.
30. Xie H, Tang SY, Cui RR, Huang J, Ren XH, Yuan
LQ, et al. Apelin and its receptor are expressed in
human osteoblasts. Regul Pept 2006; 134(2-3):
31. Tang SY, Xie H, Yuan LQ, Luo XH, Huang J, Cui
RR, et al. Apelin stimulates proliferation and
suppresses apoptosis of mouse osteoblastic cell line
MC3T3-E1 via JNK and PI3-K/Akt signaling
pathways. Peptides 2007; 28(3): 708-18.
32. Masri B, Morin N, Cornu M, Knibiehler B, Audigier
Y. Apelin (65-77) activates p70 S6 kinase and is
mitogenic for umbilical endothelial cells. FASEB J
2004; 18(15): 1909-11.
33. Li F, Li L, Qin X, Pan W, Feng F, Chen F, et al.
Apelin-induced vascular smooth muscle cell
proliferation: the regulation of cyclin D1. Front
Biosci 2008; 13: 3786-92.
34. Li B, Chen P, Wang JH, Li L, Gong JL, Yao H.
Ferrerol overcomes the invasiveness of lung
squamous cell carcinoma cells by regulating the
expression of inducers of Epithelial Mesenchymal
Transition. Microb Pathog 2017; 112: 171-5.
35. Park SK, Cho LY, Yang JJ, Park B, Chang SH, Lee
KS, et al. Lung cancer risk and cigarette smoking,
lung tuberculosis according to histologic type and
gender in a population based case-control study.
Lung Cancer 2010; 68(1): 20-6.
36. Ermin S, Cok G, Veral A, Kose T. The role of apelin
in the assessment of response to chemotherapyand
prognosis in stage 4 nonsmall cell lung cancer. Turk
J Med Sci 2016; 46(5): 1353-9.
37. Goldenberg A, Ortiz A, Kim SS, Jiang SB.
Squamous cell carcinoma with aggressive subclinical
extension: 5-year retrospective review of diagnostic
predictors. J Am Acad Dermatol 2015; 73(1):